Leo said fourth quarter so that’s up until Dec. 31. It’s only shareholders who assumed earlier, which could have been Oct. 1. Alas. It’s never that easy. If it happens in the fourth quarter it will still be amazing, and on time.
Knowing it’s going to happen will be a huge boost.
the fda could give permission to start earlier than 30 days once they receive the ind
i noted that in the last PR ipix did not mention Q4 human trials even though they wanted to let us know the fda accepted the pre ind
realistically this is looking like a 2021 trial. With so many holidays during December, it might be a difficult time to start.
what kind of interim results are we looking at? what kind of dosing? how long is a dosing regimen? ipix knew all this info when they released their last Q report. That is how they were able to put a dollar amount on the cost to do a B for C trial. They knew how much b each patient would need and for how long. they hinted in a subsequent pr they will have excess b for other trials (most likely combo trial).
News 
Market Data 
Discover 
